Institute for Clinical Genetics, TU Dresden, Dresden, Germany.
Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, Washington, USA.
Genet Med. 2018 Nov;20(11):1354-1364. doi: 10.1038/gim.2018.8. Epub 2018 Apr 19.
To estimate diagnostic yield and genotype-phenotype correlations in a cohort of 811 patients with lissencephaly or subcortical band heterotopia.
We collected DNA from 756 children with lissencephaly over 30 years. Many were tested for deletion 17p13.3 and mutations of LIS1, DCX, and ARX, but few other genes. Among those tested, 216 remained unsolved and were tested by a targeted panel of 17 genes (ACTB, ACTG1, ARX, CRADD, DCX, LIS1, TUBA1A, TUBA8, TUBB2B, TUBB, TUBB3, TUBG1, KIF2A, KIF5C, DYNC1H1, RELN, and VLDLR) or by whole-exome sequencing. Fifty-five patients studied at another institution were added as a validation cohort.
The overall mutation frequency in the entire cohort was 81%. LIS1 accounted for 40% of patients, followed by DCX (23%), TUBA1A (5%), and DYNC1H1 (3%). Other genes accounted for 1% or less of patients. Nineteen percent remained unsolved, which suggests that several additional genes remain to be discovered. The majority of unsolved patients had posterior pachygyria, subcortical band heterotopia, or mild frontal pachygyria.
The brain-imaging pattern correlates with mutations in single lissencephaly-associated genes, as well as in biological pathways. We propose the first LIS classification system based on the underlying molecular mechanisms.
在 811 例无脑回畸形或皮质下带状异位症患者的队列中,估计诊断产量和基因型-表型相关性。
我们收集了 30 多年来 756 名无脑回畸形患儿的 DNA。许多人接受了 17p13.3 缺失和 LIS1、DCX 和 ARX 突变的检测,但很少有人接受其他基因的检测。在这些接受检测的人中,有 216 人仍然未解决,他们接受了 17 个基因(ACTB、ACTG1、ARX、CRADD、DCX、LIS1、TUBA1A、TUBB2B、TUBB、TUBB3、TUBG1、KIF2A、KIF5C、DYNC1H1、RELN 和 VLDLR)的靶向基因面板或全外显子组测序检测。另外还增加了在另一家机构研究的 55 名患者作为验证队列。
整个队列的总突变频率为 81%。LIS1 占 40%的患者,其次是 DCX(23%)、TUBA1A(5%)和 DYNC1H1(3%)。其他基因占患者的 1%或更少。19%的患者仍然未解决,这表明还有几个额外的基因有待发现。大多数未解决的患者存在后极巨脑回、皮质下带状异位症或轻度额极巨脑回。
脑成像模式与单一无脑回畸形相关基因以及生物途径的突变相关。我们提出了第一个基于潜在分子机制的 LIS 分类系统。